HNRPH1 (HNRNPH1) Human shRNA Lentiviral Particle (Locus ID 3187)

CAT#: TL312375V

HNRNPH1 - Human shRNA lentiviral particles (4 unique 29mer target-specific shRNA, 1 scramble control), 0.5 ml each, >10^7 TU/ml.

Specifications

Product Data

• Locus ID: 3187
• Synonyms: hnRNPH; HNRPH; HNRPH1
• Vector: pGFP-C-shLenti
• Format: Lentiviral particles
• RefSeq: NM_001257293, NM_005520, NM_005520.1, NM_005520.2, NM_001257293.1, BC001348, BC001348.2, NM_001364233, NM_001363572, NM_001364227, NM_001364228, NM_001364234, NM_001364236, NM_001364237, NM_001364239, NM_001364242, NM_001364244, NM_001364245, NM_001364247, NM_001364251, NM_001364252, NM_001364253, NM_001364255, NM_001364225, NM_001364226, NM_001364229, NM_001364230, NM_001364231, NM_001364232, NM_001364235, NM_001364238, NM_001364240, NM_001364241, NM_001364243, NM_001364246, NM_001364248, NM_001364250, NM_001364254, NM_005520.3, NM_001257293.2
• UniProt ID: P31943
• Summary: This gene encodes a member of a subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins that complex with heterogeneous nuclear RNA. These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some may shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has three repeats of quasi-RRM domains that bind to RNA and is very similar to the family member HNRPF. This gene may be associated with hereditary lymphedema type I. Alternatively spliced transcript variants have been described [provided by RefSeq, Mar 2012]
• shRNA Design: These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service.
• Performance Guaranteed: OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
  
  For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).